NKGen Biotech, Inc. (NKGN)
NASDAQ: NKGN · Real-Time Price · USD
0.501
+0.022 (4.50%)
Jan 22, 2025, 10:15 AM EST - Market open

NKGen Biotech Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2023 FY 2022 FY 2021
Period Ending
Jan '25 Dec '23 Dec '22 Dec '21
Market Capitalization
1860--
Enterprise Value
4571--
Last Close Price
0.482.759.959.69
PB Ratio
-0.45-1.03--
Debt / Equity Ratio
-0.40-0.347.70-1.37
Asset Turnover
--0.00-
Quick Ratio
0.000.000.010.01
Current Ratio
0.020.050.020.01
Return on Assets (ROA)
-106.84%-113.32%-88.47%-
Return on Capital (ROIC)
---110.60%-
Earnings Yield
-508.57%-137.81%--
FCF Yield
-124.11%-36.46%--
Buyback Yield / Dilution
-250.53%-142.70%55.39%-
Total Shareholder Return
-250.53%-142.70%55.39%-
Source: S&P Capital IQ. Standard template. Financial Sources.